1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Full application due 6/8/2026 at 8pm EST; Letter of Intent due 3/2/2026
"Accelerating Impact for Hard-to-Treat Cancers Award" is currently closed and not accepting applications.
Accelerating Impact for Hard-to-Treat Cancers Award is sponsored by Children's Cancer Research Fund. This funding opportunity supports pre-clinical research aimed at prevention, early detection, treatment, and improving outcomes for pediatric cancers that remain hard-to-treat. It includes basic and translational studies, pilot and feasibility studies, and development of new methods or technologies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Research Grant Programs - Children's Cancer Research Fund Children’s Cancer Research Fund (CCRF) is a national nonprofit committed to finding safer, more effective therapies for kids battling cancer. Thanks to donors and partners around the country, we have contributed over $235 million to research, education and awareness, and quality-of-life programs for childhood cancer families.
We believe kids deserve safer, less toxic treatments, and we’re committed to funding groundbreaking research and services that enhance healing and care. In 2026, Children’s Cancer Research Fund will focus our research funding efforts on three main areas: All applications for CCRF awards must be submitted through ProposalCentral .
Interested applicants should create a profile and once logged in, visit the “Grant Opportunities” tab in Proposal Central and select the corresponding CCRF grant application to apply. Please note that CCRF will only accept one LOI per Principal Investigator each year.
Clinical Trials for Hard-to-Treat Cancers Accelerating Impact for Hard-to-Treat Cancers Award This funding opportunity supports pre-clinical research aimed at prevention, early detection, treatment, and improving outcomes for pediatric cancers that remain hard-to-treat.
We fund basic and translational studies, including pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, and development of new methods or technologies. Learn more about eligibility criteria and how hard-to-treat cancers are defined below.
View 2026 CCRF Hard-to-Treat Cancers Grant Application Guidelines Healthy After Cancer: Childhood Cancer Survivorship Award This funding opportunity supports research to improve the quality and length of life for childhood, adolescent, and young adult cancer survivors by preventing and addressing the late effects of cancer therapy.
It prioritizes interventions and translational projects focused on survivorship, rather than developing new cancer treatments. Learn more about eligibility criteria and other key details below.
View 2026 CCRF Childhood Cancer Survivorship Application Guidelines Eliminating Disparities in Childhood Cancers Award This funding opportunity supports research aimed at reducing health disparities in childhood cancer across incidence, access to care, treatment outcomes, and survivorship.
Proposals that identify modifiable risk factors, elaborate mechanisms of disparities or inequities, or which plausibly propose to reduce them, will have greater priority for funding than proposals that simply describe them. Learn more about eligibility criteria and other key details below.
View 2026 CCRF Eliminating Disparities in Childhood Cancers Application Guidelines Accelerating Hope: Clinical Trials for Hard-to-Treat Cancers Award This funding opportunity is limited to support for clinical trials focused on hard-to-treat cancers, prioritizing Phase 0 – Phase 2 studies. Learn more about eligibility criteria and other key details below.
View 2026 CCRF Clinical Trials Application Guidelines Type and Press “enter” to Search
According to the current listing, eligibility includes: Supports pre-clinical research aimed at prevention, early detection, treatment, and improving outcomes for pediatric cancers that remain hard-to-treat; funds basic and translational studies including pilot projects. Confirm the full requirements in the official notice before applying.
The current listing shows $250,000 for a two-year period. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 8, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Accelerating Impact for Hard-to-Treat Cancers Award is funded by Children's Cancer Research Fund. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
William Penn's 128-grant, $57.2M May 2026 distribution reveals a Philadelphia-focused funder doubling down on children, arts education, and civic infrastructure as federal support recedes.
Read articleRFA-ES-28-004 went up as a forecast on September 24, 2026: 10 expected awards at $500,000 to $750,000 each, recompeting a network that currently has six translation centers and one coordinator. The four new slots are almost certainly geographic.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read article